| PMCB Snapshot | |
|---|---|
| PharmaCyte Biotech, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cell therapies for cancer and diabetes in the United States. The company is headquartered in Laguna Hills, California. | |
| VALUATION DATA | |
| Market Capitalization | $17,921,200 | Price to Sales | 1.00 |
| Earnings per Share | $-1.4800 |
| PE Ratio | None |
| PRICE DATA | |
| Most Recent Close | $2.1300 |
| 52 Week High | $- |
| 52 Week Low | $0.601 |
| 50-Day Moving Average | $- |
| 200-Day Moving Average | $6.03 |
| All data are from Alpha Vantage as of today. For more infomation on PMCB see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search